Carbon nanotubes (CNTs) have well-defined hollow interiors and exhibit unusual mechanical and thermal stability as well as electron conductivity. This opens intriguing possibilities to introduce other matter into the cavities, which may lead to nanocomposite materials with interesting properties or behaviour different from the bulk. Here, we report a striking enhancement of the catalytic activity of Rh particles confined inside nanotubes for the conversion of CO and H2 to ethanol. The overall formation rate of ethanol (30.0 mol mol(-1)Rh h(-1)) inside the nanotubes exceeds that on the outside of the nanotubes by more than an order of magnitude, although the latter is much more accessible. Such an effect with synergetic confinement has not been observed before in catalysis involving CNTs. We believe that our discovery may be of a quite general nature and could apply to many other processes. It is anticipated that this will motivate theoretical and experimental studies to further the fundamental understanding of the host-guest interaction within carbon and other nanotube systems.

In this contribution we have developed a useful and experimentally easy way to use C60 powder to directly fabricate C60 nanotubes with a mondisperse size distribution and uniform orientation. The structure of C60 nanotubes was confirmed by SEM, TEM, and FT-IR.

The thalassemias are compelling targets for therapeutic genome editing in part because monoallelic correction of a subset of hematopoietic stem cells (HSCs) would be sufficient for enduring disease amelioration. A primary challenge is the development of efficient repair strategies that are effective in HSCs. Here, we demonstrate that allelic disruption of aberrant splice sites, one of the major classes of thalassemia mutations, is a robust approach to restore gene function. We target the IVS1-110G>A mutation using Cas9 ribonucleoprotein (RNP) and the IVS2-654C>T mutation by Cas12a/Cpf1 RNP in primary CD34+ hematopoietic stem and progenitor cells (HSPCs) from β-thalassemia patients. Each of these nuclease complexes achieves high efficiency and penetrance of therapeutic edits. Erythroid progeny of edited patient HSPCs show reversal of aberrant splicing and restoration of β-globin expression. This strategy could enable correction of a substantial fraction of transfusion-dependent β-thalassemia genotypes with currently available gene-editing technology.

An infant with Hb SE disease is reported. He was clinically well. Review of the literature shows that patients aged 18 and younger are usually well. On the other hand, more than half of those aged 20 and older developed sickling-related complications, including potentially lifethreatening acute chest syndrome. These patients have 60-65% Hb S, similar to the percent Hb S in patients with Hb S/b 1 -thalassemia. Their hematological features and clinical course appear to parallel those of Hb S/b 1 -thalassemia. Patients have variable levels of anemia, and some develop clinical complications. With population migrations and increasing racial intermarriages, Hb SE disease is expected to be encountered more often around the globe. Patients with Hb SE disease should be followed and managed in a similar fashion as those with Hb S/b 1 -thalassemia, and treated appropriately when they develop sickling-related symptoms and complications. Am. J. Hematol. 82:643-649, 2007. V V C 2007 Wiley-Liss, Inc.

No abstract

SummarySickle cell anemia affects millions of people worldwide and is an emerging global health burden. As part of a large NIH-funded NextGen Consortium, we generated a diverse, comprehensive, and fully characterized library of sickle-cell-disease-specific induced pluripotent stem cells (iPSCs) from patients of different ethnicities, β-globin gene (HBB) haplotypes, and fetal hemoglobin (HbF) levels. iPSCs stand to revolutionize the way we study human development, model disease, and perhaps eventually, treat patients. Here, we describe this unique resource for the study of sickle cell disease, including novel haplotype-specific polymorphisms that affect disease severity, as well as for the development of patient-specific therapeutics for this phenotypically diverse disorder. As a complement to this library, and as proof of principle for future cell- and gene-based therapies, we also designed and employed CRISPR/Cas gene editing tools to correct the sickle hemoglobin (HbS) mutation.

No abstract

Detection of adulteration in extra virgin olive oil (EVOO) is one of the main aspects in the quality control. In this study, we sought to identify the adulterated oil from EVOO to discriminate the type of adulterants and to quantify the levels of adulteration using FT-IR spectroscopy coupled with chemometrics. Supervised locally linear embedding (SLLE) was employed to reduce the dimensionality of variables and then compared with principal component analysis and locally linear embedding. The results show that SLLE gave satisfactory results. Nearest centroid classification and PLS regression methods were applied to establish the classification and quantification models for EVOO adulteration using the compressed low dimensional FT-IR data. The results have shown that we can clearly identify which edible oils are adulterated and accurately quantify the percentage of adulteration in EVOO.